Search results
Results from the WOW.Com Content Network
This is a list of investigational attention deficit hyperactivity disorder drugs, or drugs that are currently under development for clinical use in the treatment of attention deficit hyperactivity disorder (ADHD) but are not yet approved. Chemical/generic names are listed first, with developmental code names, synonyms, and brand names in ...
Attention deficit hyperactivity disorder management options are evidence-based practices with established treatment efficacy for ADHD.Approaches that have been evaluated in the management of ADHD symptoms include FDA-approved pharmacologic treatment and other pharmaceutical agents, psychological or behavioral approaches, combined pharmacological and behavioral approaches, cognitive training ...
The extended release form has been approved by the FDA for the treatment of attention-deficit hyperactivity disorder (ADHD) in children as an alternative to stimulant medications. Its beneficial actions are likely due to its ability to strengthen prefrontal cortical regulation of attention and behavior.
Guanfacine. Guanfacine, sold under the brand name Tenex ( immediate-release) and Intuniv ( extended-release) among others, is an oral alpha-2a agonist medication used to treat attention deficit hyperactivity disorder (ADHD) and high blood pressure. [ 3][ 9] Guanfacine is FDA-approved for monotherapy treatment of ADHD, [ 3] as well as being used ...
Prescriptions for attention deficit/hyperactivity disorder medications spiked in the first year of the pandemic, according to a report published Thursday by the Centers for Disease Control and ...
Viloxazine. Viloxazine, sold under the brand name Qelbree among others, is a selective norepinephrine reuptake inhibitor medication which is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children and adults. [ 1][ 5] It was marketed for almost 30 years as an antidepressant for the treatment of depression before ...
Lisdexamfetamine, sold under the brand names Vyvanse and Elvanse among others, is a stimulant medication that is used medically to treat attention deficit hyperactivity disorder (ADHD) in children and adults, moderate-to-severe binge eating disorder in adults, and cognitive disengagement syndrome (CDS) in adults.
In October 2022, the FDA announced a shortage of Adderall. Since then, doctors say other ADHD medications, such as Focalin, Ritalin and Vyvanse, have become in short supply. As of 2022, there were ...